Why New Treatments for Hyperhidrosis Should Be on Your Radar

This program will include a discussion of off-label treatment and devices and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

Hyperhidrosis by the Numbers

Case 1 Sebastian

What Do Pediatricians Need to Know About HH?

QoL Is the Severity Scale

Treatment Options for Pediatric HH

Antiperspirants

How Antiperspirants Work

Iontophoresis

Case 2 Cassie

Evaluating the Adult Patient With HH

IHHS Treatment Algorithm

Oral Medications

Pathophysiology of HH

Considerations in Treatment Selection for Pediatric HH

Case 3 Patrick

Treatment Options for Patrick

OnobotulinumtoxinA

OnabotulinumtoxinA in Adolescent Patients

OnabotulinumtoxinA in Adult Patients

Managing Side Effects

Other Treatments

Topical Anticholinergic Glycopyrronium Tosylate in Adult and Adolescent Patients

Topical Anticholinergic Sofpironium Bromide in Adult Patients

Conclusion and Key Takeaways

Abbreviations